We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$490M
AUM Growth
+$17M
Cap. Flow
+$17.7M
Cap. Flow %
3.6%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$13.5M
2
STAA icon
STAAR Surgical
STAA
+$5.13M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Consumer Staples 35.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.5B
$173M 35.35%
19,189,632
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$160M 32.73%
1,619,968
-11,000
-0.7% -$1.01M
STAA icon
3
STAAR Surgical
STAA
$1.14B
$67.6M 13.79%
7,417,582
+530,487
+8% +$5.13M
LCTX icon
4
Lineage Cell Therapeutics
LCTX
$263M
$66.5M 13.57%
22,095,035
+5,006,257
+29% +$13.5M
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$22.4M 4.57%
817,029
– –
MNST icon
6
PUT
Monster Beverage
MNST
$87.5B
– –
-6,000,000
Closed -$45.8M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q4 2014 Portfolio in Review

As of Q4 2014, Broadwood Capital held 6 positions worth $490M, up 3.6% from $473M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital deployed $17.7M of net new capital in Q4 2014, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 59% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $1.01M trimmed.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q4 2014, an estimated $13.5M increase.
  • Broadwood Capital's biggest Q4 2014 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $1.01M.
  • Broadwood Capital's ten largest holdings make up 100% of its $490M portfolio in Q4 2014.
  • Broadwood Capital opened 0 new positions and closed 1 in Q4 2014.
  • Broadwood Capital's portfolio value rose 3.6% quarter-over-quarter to $490M.

Based on Broadwood Capital's 13F filing for Q4 2014, filed 17 Feb 2015.